🔥 Wednesday 14 January 2026 Wed, 14 Jan 2026

MetalsTech Limited is progressing its Pre-Feasibility Study for the Sturec Gold Mine in Slovakia, targeting completion in the first half of 2026, alongside key board appointments aimed at driving the project forward.

3D Energi has confirmed a new gas discovery at the Charlemont-1 well in Victoria’s Otway Basin, reinforcing the prospectivity of the Charlemont Trend and the potential for increased domestic gas supply.

Atomic Eagle Limited has completed a 69-hole drilling program at its Chisebuka target in Zambia, revealing extensive shallow uranium mineralisation and setting the stage for a major resource upgrade across the Muntanga Project.

Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.

Ballymore Resources has reported its richest drill intersection yet at the Torpy’s prospect near Chillagoe, Queensland, revealing exceptionally high-grade silver, lead, zinc, and indium mineralisation. This breakthrough highlights the growing potential of the Torpy’s area and sets the stage for further exploration in 2026.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Norfolk Metals has completed Phase #1 of its maiden drilling campaign at the Carmen Copper Project in Chile, confirming significant higher-grade copper sulphide mineralisation open at depth. The company also secured firm commitments for a $2.1 million placement to fund ongoing exploration.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

Polymetals Resources has resumed operations at its Endeavor Mine following a tragic incident, completing first concentrate shipments and securing $34.4 million in new capital to support exploration and ramp-up.

Stavely Minerals has initiated an updated 2026 Scoping Study for its copper-gold project in Western Victoria, driven by significantly higher metal prices and improved economic prospects since 2022.

Stellar Resources has reported significant progress in its December quarter, advancing the Heemskirk Tin Project through robust drilling results and metallurgical studies, supported by a $9.5 million capital raise.

Terra Metals has confirmed a new platinum group metal-copper-nickel sulfide discovery at the SW5 target within its Dante Project, revealing a significant expansion of mineralisation beyond existing resources. This second discovery complements the earlier SW6 find and underscores the potential scale of the magmatic sulfide system in Western Australia.

Power Minerals has terminated its joint venture with Navigate Energy on the Rincon Lithium Project, opting to retain full ownership and seek new partners amid a buoyant lithium market.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Southern Cross Gold Consolidated Ltd throws its weight behind Australia’s new A$1.2 billion Critical Minerals Strategic Reserve, spotlighting its Sunday Creek gold-antimony project as a key player in securing domestic supply and reducing reliance on China.

Resolution Minerals reports outstanding high-grade antimony, silver, and gold assay results from rock samples at its Antimony Ridge Mine in Idaho, reinforcing the project's strategic importance in the US critical minerals landscape.

Diablo Resources has confirmed multiple high-grade silver, gold, copper, and antimony systems at its Star Range Project in Utah, setting the stage for its maiden drilling campaign.

Prospect Resources has confirmed significant gold by-product mineralisation at its Nyungu Central deposit, potentially boosting the economics of the Mumbezhi Copper Project in Zambia. Updated resource estimates incorporating these findings are expected in Q1 2026.

Predictive Discovery has secured a crucial court approval for its acquisition of Robex Resources, paving the way for the deal to close in early 2026 pending final regulatory consents.

Racura Oncology has launched a strategic collaboration with Emory University to investigate (E,E)-bisantrene’s potential to overcome resistance to osimertinib in EGFR-mutated non-small cell lung cancer. This partnership aims to bolster Racura’s HARNESS-1 clinical trial and strengthen its position in the competitive lung cancer treatment landscape.

Robex Resources has received final court approval for its merger with Predictive Discovery, setting the stage for completion in early 2026 pending regulatory consents. This move could reshape the future of Robex’s West African gold projects.

Viking Mines reports promising high-grade tungsten oxide assay results from its Linka Tungsten Project in Nevada, reinforcing the project's potential amid soaring global scheelite prices.

BlueScope announces a $1.00 per share unfranked special dividend, returning $438 million to shareholders from recent asset sales and working capital releases. The steelmaker signals a robust cash flow outlook with a planned capex reduction in FY2027.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.